-
Health authorities in the UK report an early spike in flu cases driven by the H3N2 strain, with hospital admissions rising and vaccination efforts underway. Meanwhile, global TB cases decline slightly but face funding threats, risking reversal of progress. Experts warn of a challenging winter for health services worldwide.
-
Gaza faces a severe health crisis with rising infectious diseases, including poliovirus and Guillain-Barré syndrome, driven by water contamination, infrastructure destruction, and ongoing conflict. Medical supplies are critically low, and hospitals are overwhelmed, highlighting the urgent need for aid and infrastructure repair.
-
As of early October 2025, the Stratus COVID-19 variant (XFG and XFG.3) has become dominant in the US, causing persistent respiratory symptoms but no increased severity. Meanwhile, Japan faces an unusually early and rapid influenza epidemic, with hospitals filling and schools closing. Experts urge vaccination and hygiene to mitigate these overlapping respiratory threats.
-
England is set to approve cabotegravir, a two-month injectable HIV prevention shot, expanding options for those unable to take daily pills. Zimbabwe will roll out lenacapavir, a twice-yearly prophylactic, amid debates over cost and safety. Both developments mark significant advances in HIV prevention efforts.
-
Texas Attorney General Ken Paxton has filed a lawsuit against Johnson & Johnson and Kenvue, alleging deceptive marketing of Tylenol to pregnant women amid unproven claims linking the drug to autism. The case follows recent political statements by Trump and Kennedy suggesting a connection, which medical experts strongly dispute. The companies defend Tylenol's safety, citing scientific consensus.